Maya Moscovich-Eiger

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Corrigendum to Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma. Am J Ophthalmol. 2026;285:318-323.

Corrigendum to Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma. Am J Ophthalmol. 2026;285:318-323.

Journal: American journal of ophthalmology

Published: August 14, 2026

Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma.

Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma.

Journal: American journal of ophthalmology

Published: April 25, 2026

CCR1 signaling as a common injury pathway in retinal degeneration.

CCR1 signaling as a common injury pathway in retinal degeneration.

Journal: Journal of neuroinflammation

Published: February 03, 2026

Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma.

Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma.

Journal: American journal of ophthalmology

Published: November 01, 2025

Pulled-in-two syndrome in a young woman with restrictive strabismus and rare genetic mutation.

Pulled-in-two syndrome in a young woman with restrictive strabismus and rare genetic mutation.

Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus

Published: March 23, 2025

Brain MRI Screening for Bilateral Retinoblastoma Patients.

Brain MRI Screening for Bilateral Retinoblastoma Patients.

Journal: Seminars in ophthalmology

Published: January 08, 2025

NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDY.

NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDY.

Journal: Retina (Philadelphia, Pa.)

Published: December 02, 2024

Evolving trends in retinoblastoma management: A 16-year clinicopathological analysis of enucleated eyes.

Evolving trends in retinoblastoma management: A 16-year clinicopathological analysis of enucleated eyes.

Journal: Taiwan journal of ophthalmology

Published: September 11, 2024

Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients.

Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients.

Journal: Clinical & experimental ophthalmology

Published: August 23, 2024

HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents.

HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents.

Journal: Retina (Philadelphia, Pa.)

Published: August 16, 2024

Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma.

Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma.

Journal: American journal of ophthalmology

Published: June 24, 2024

An interactive and explainable AI approach to improve human-machine teaming in cancer subtyping from digital cytopathology.

An interactive and explainable AI approach to improve human-machine teaming in cancer subtyping from digital cytopathology.

Journal: Medical image analysis

Published: March 29, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026